🇺🇸 FDA
Pipeline program

18FMC225_FPG

P-gp-TRD

Phase 2 small_molecule active

Quick answer

18FMC225_FPG for depression is a Phase 2 program (small_molecule) at Fondazione Telethon ETS with 1 ClinicalTrials.gov record(s).

Program details

Company
Fondazione Telethon ETS
Indication
depression
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials